MEP88408A - Pharmaceutical compositions containing oligosaccharides and preparation thereof - Google Patents
Pharmaceutical compositions containing oligosaccharides and preparation thereofInfo
- Publication number
- MEP88408A MEP88408A MEP-884/08A MEP88408A MEP88408A ME P88408 A MEP88408 A ME P88408A ME P88408 A MEP88408 A ME P88408A ME P88408 A MEP88408 A ME P88408A
- Authority
- ME
- Montenegro
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- containing oligosaccharides
- oligosaccharides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pain & Pain Management (AREA)
- Materials Engineering (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0003910A FR2807043B1 (fr) | 2000-03-28 | 2000-03-28 | Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation |
PCT/FR2001/000903 WO2001072762A1 (fr) | 2000-03-28 | 2001-03-26 | Compositions pharmaceutiques contenant des oligosaccharides et leur preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP88408A true MEP88408A (en) | 2011-12-20 |
Family
ID=8848572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-884/08A MEP88408A (en) | 2000-03-28 | 2001-03-26 | Pharmaceutical compositions containing oligosaccharides and preparation thereof |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1272499B1 (sk) |
JP (1) | JP2003529570A (sk) |
KR (1) | KR20030001394A (sk) |
CN (1) | CN1183149C (sk) |
AR (1) | AR034251A1 (sk) |
AT (1) | ATE290543T1 (sk) |
AU (1) | AU782713B2 (sk) |
BR (1) | BR0109617A (sk) |
CA (1) | CA2403906A1 (sk) |
DE (1) | DE60109279T2 (sk) |
EA (1) | EA004768B1 (sk) |
EE (1) | EE200200551A (sk) |
ES (1) | ES2236206T3 (sk) |
FR (1) | FR2807043B1 (sk) |
HK (1) | HK1056564A1 (sk) |
HU (1) | HUP0300330A3 (sk) |
IL (1) | IL151832A0 (sk) |
ME (1) | MEP88408A (sk) |
MX (1) | MXPA02009455A (sk) |
NO (1) | NO20024590D0 (sk) |
NZ (1) | NZ521558A (sk) |
PL (1) | PL204419B1 (sk) |
PT (1) | PT1272499E (sk) |
SK (1) | SK286745B6 (sk) |
WO (1) | WO2001072762A1 (sk) |
YU (1) | YU72802A (sk) |
ZA (1) | ZA200207707B (sk) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6750207B1 (en) * | 1992-05-01 | 2004-06-15 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
FR2845686B1 (fr) * | 2002-10-10 | 2013-08-30 | Aventis Pharma Sa | Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant |
US7511026B2 (en) * | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
FR2857971B1 (fr) * | 2003-07-24 | 2005-08-26 | Aventis Pharma Sa | Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant |
US20050186679A1 (en) * | 2004-02-24 | 2005-08-25 | Christian Viskov | Method for determining specific groups constituting heparins or low molecular weight heparins |
JP5116071B2 (ja) | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | D−アロースおよびd−プシコースの抗神経因性疼痛効果の利用 |
JP5137118B2 (ja) | 2005-08-30 | 2013-02-06 | 国立大学法人高知大学 | ユニバーサル塩基 |
EP3418287A1 (en) * | 2017-06-21 | 2018-12-26 | Universität für Bodenkultur Wien | Chemical release of asparaginelinked glycans |
CN115317507A (zh) * | 2022-09-19 | 2022-11-11 | 中国科学院海洋研究所 | 低分子量褐藻多糖硫酸酯在制备抗多动症药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449688A (en) * | 1993-03-30 | 1995-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | Method of treating chronic inflammatory diseases |
-
2000
- 2000-03-28 FR FR0003910A patent/FR2807043B1/fr not_active Expired - Fee Related
-
2001
- 2001-03-26 SK SK1393-2002A patent/SK286745B6/sk not_active IP Right Cessation
- 2001-03-26 NZ NZ521558A patent/NZ521558A/en not_active IP Right Cessation
- 2001-03-26 AT AT01919561T patent/ATE290543T1/de not_active IP Right Cessation
- 2001-03-26 BR BR0109617-6A patent/BR0109617A/pt not_active IP Right Cessation
- 2001-03-26 CA CA002403906A patent/CA2403906A1/fr not_active Abandoned
- 2001-03-26 YU YU72802A patent/YU72802A/sh unknown
- 2001-03-26 KR KR1020027012867A patent/KR20030001394A/ko not_active Application Discontinuation
- 2001-03-26 EP EP01919561A patent/EP1272499B1/fr not_active Expired - Lifetime
- 2001-03-26 JP JP2001570671A patent/JP2003529570A/ja active Pending
- 2001-03-26 WO PCT/FR2001/000903 patent/WO2001072762A1/fr not_active Application Discontinuation
- 2001-03-26 CN CNB018084087A patent/CN1183149C/zh not_active Expired - Fee Related
- 2001-03-26 AU AU46639/01A patent/AU782713B2/en not_active Ceased
- 2001-03-26 ES ES01919561T patent/ES2236206T3/es not_active Expired - Lifetime
- 2001-03-26 MX MXPA02009455A patent/MXPA02009455A/es active IP Right Grant
- 2001-03-26 IL IL15183201A patent/IL151832A0/xx unknown
- 2001-03-26 DE DE60109279T patent/DE60109279T2/de not_active Expired - Fee Related
- 2001-03-26 ME MEP-884/08A patent/MEP88408A/xx unknown
- 2001-03-26 EA EA200201024A patent/EA004768B1/ru not_active IP Right Cessation
- 2001-03-26 PL PL357301A patent/PL204419B1/pl unknown
- 2001-03-26 EE EEP200200551A patent/EE200200551A/xx unknown
- 2001-03-26 HU HU0300330A patent/HUP0300330A3/hu unknown
- 2001-03-26 PT PT01919561T patent/PT1272499E/pt unknown
- 2001-03-27 AR ARP010101456A patent/AR034251A1/es unknown
-
2002
- 2002-09-25 NO NO20024590A patent/NO20024590D0/no unknown
- 2002-09-25 ZA ZA200207707A patent/ZA200207707B/en unknown
-
2003
- 2003-11-26 HK HK03108634A patent/HK1056564A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP9509A (en) | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof | |
TR199901578T2 (xx) | Klaritromisin form 0 kristali | |
ATE286500T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate | |
ATE409048T1 (de) | Pharmazeutisch aktive oligosaccharid-conjugate | |
DE60112609D1 (en) | Pyrazolopyridine | |
ES2104754T3 (es) | Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
GEP20094676B (en) | Piperidine compounds and pharmaceutical compositions containing them | |
IS6658A (is) | Ný efnasambönd | |
HUP0105437A2 (hu) | Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
BRPI0416276A (pt) | lactames macrocìclicos e uso farmacêutico dos mesmos | |
MY115339A (en) | Compositions containing micronized nebivolol | |
DE60112330D1 (en) | Pyrazolopyridinderivate | |
EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
MEP9309A (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same | |
ME00106B (me) | Derivati aminoalkenilbenzoil-benzofurana ili benzotiopena, postupak za njihovo pripremanje i kompozicije koje ih sadrže | |
ES2036926A1 (es) | "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina". | |
MEP88408A (en) | Pharmaceutical compositions containing oligosaccharides and preparation thereof | |
TR200401052T4 (tr) | Yeni bileşikler | |
CA2107485A1 (fr) | Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
BR0211030A (pt) | Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole | |
SE9904128D0 (sv) | Novel compounds | |
YU37597A (en) | New pyranosid derivatives | |
YU4497A (sh) | Novi heteroaril - oksazolidinoni | |
HRP20060040A2 (en) | PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS | |
HUP0004701A2 (hu) | Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására |